Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold
Xconomy
AUGUST 18, 2020
A Phase 1 trial testing a Poseida Therapeutics cell therapy in men with prostate cancer is on hold after a patient enrolled in the study died of liver failure nearly three weeks after receiving the treatment.
Let's personalize your content